Skip to content

Optimized regimen based on the vonoprazan-amoxicillin dual therapy in the treatment of Helicobacter pylori infection: a clinical study

Optimized regimen based on the vonoprazan-amoxicillin dual therapy in the treatment of Helicobacter pylori infection: a clinical study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065864
Enrollment
Unknown
Registered
2022-11-17
Start date
2022-11-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori

Interventions

Experimental group 1:High dose Amoxicillin + Vonoprazan
Experimental group 2:Amoxicillin + Vonoprazan + Saccharomyces boulardii

Sponsors

The Affiliated Changzhou Second People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years old, male or female; 2. No antibiotics, bismuth, H2 receptor antagonists or proton pump inhibitors were used in the last four weeks; 3. 13C urea breath test or rapid urease test positive; 4. Have indications of Helicobacter pylori eradication treatment and are willing to cooperate with the doctor to conduct a follow-up investigation of the eradication effect.

Exclusion criteria

Exclusion criteria: 1. Severe heart, liver and kidney damage; 2. Pregnant or lactating women; 3. Previous history of upper digestive tract surgery, gastric malignancy, liver and kidney function damage, pyloric stenosis, pregnancy, etc.; 4. Patients taking NSAIDS or drinking alcohol at the same time; 5. Patients who are allergic to any drug of the eradication program.

Design outcomes

Primary

MeasureTime frame
Eradication rate;

Secondary

MeasureTime frame
Compliance;Adverse Events;

Countries

China

Contacts

Public ContactXiaoyong Wang

The Affiliated Changzhou Second People's Hospital of Nanjing Medical University

wxy20009@126.com+86 13775051593

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026